BAJAJ BROKING

Notification close image
No new Notification messages
card image
Seshaasai Technologies Ltd IPO
Apply for the Seshaasai Technologies Ltd IPO through UPI in Just minutes
delete image
card image
Start your SIP with just ₹100
Choose from 4,000+ Mutual Funds on Bajaj Broking
delete image
card image
Open a Free Demat Account
Pay ZERO maintenance charges for the first year, get free stock picks daily, and more.
delete image
card image
Trade Now, Pay Later with up to 4x
Never miss a good trading opportunity due to low funds with our MTF feature.
delete image
card image
Track Market Movers Instantly
Stay updated with real-time data. Get insights at your fingertips.
delete image

Dr. Lal PathLabs Q2 FY26 Results Preview: Revenue Seen at ₹ 730 Cr, PAT at ₹ 151 Cr

Synopsis:


Dr. Lal PathLabs is expected to post revenue of ₹ 730 Cr in Q2 FY26, up 11.2 % YoY. EBITDA is estimated at ₹ 218 Cr, a 7.8 % YoY increase, while PAT is projected at ₹ 151 Cr, marking 17 % YoY and 14.1 % QoQ growth.

 Source: Bloomberg Estimates

Dr. Lal PathLabs Ltd. will announce its Q2 FY26 results on October 31, 2025, followed by a conference call at 4:30 PM. The quarter is expected to show sustained double-digit growth in revenue and profit, supported by steady demand for diagnostic services and a gradual normalization in operating costs.

Revenue for the quarter is estimated at ₹ 730 Cr, an increase of 11.2 % YoY and 9.6 % QoQ. Operating profit (EBITDA) is projected at ₹ 218 Cr, translating to 7.8 % YoY and 13.5 % sequential growth. Operating margins are expected at 29.7 %, compared with 30.7 % in Q2 FY25 and 28.7 % in Q1 FY26 a decline of 94 bps YoY but an improvement of 103 bps QoQ.

Net profit (PAT) is projected at ₹ 151 Cr, up 17 % from last year and 14.1 % from the previous quarter. This reflects a solid recovery in earnings aided by controlled expenditure and higher test volumes.

DR. LAL PATH LABS LTD.

Trade

3135.546.10 (1.49 %)

Updated - 31 October 2025
3208.90day high
DAY HIGH
3063.00day low
DAY LOW
528369
VOLUME (BSE)

Dr. Lal PathLabs Q2 FY26 Preview

Particulars

Q2 FY26E

Q2 FY25

YoY

Q1 FY26

QoQ

Revenue (₹ Bn)

7.3

6.6

11.2 %

6.70

9.6 %

EBITDA (₹ Bn)

2.18

2.0

7.8 %

1.92

13.5 %

EBITDA Margin (%)

29.7 %

30.7 %

-94 bps

28.7 %

+103 bps

PAT (₹ Cr)

1.51

1.29

17.0 %

1.32

14.1 %

Overall Outlook

Dr. Lal PathLabs’ Q2 FY26 estimates highlight steady revenue growth and a notable increase in profitability. While margins remain slightly below the previous year’s levels, a sequential recovery signals operational efficiency improvement. The results announcement and management commentary on October 31 will offer greater clarity on demand trends, cost optimisation, and network expansion.

Disclaimer:
This content has been published for informational purposes only. Bajaj Broking is not affiliated with, nor does it endorse or assume any responsibility for, the source material. Readers are advised to consult the original publication for complete and accurate context.

Frequently Asked Questions

No result found

search icon

Read More Blogs

Disclaimer :

The information on this website is provided on "AS IS" basis. Bajaj Broking (BFSL) does not warrant the accuracy of the information given herein, either expressly or impliedly, for any particular purpose and expressly disclaims any warranties of merchantability or suitability for any particular purpose. While BFSL strives to ensure accuracy, it does not guarantee the completeness, reliability, or timeliness of the information. Users are advised to independently verify details and stay updated with any changes. The securities are quoted as an example and not as a recommendation. Past performance is not necessarily a guide to future performance.

The information provided on this website is for general informational purposes only and is subject to change without prior notice. BFSL shall not be responsible for any consequences arising from reliance on the information provided herein and shall not be held responsible for all or any actions that may subsequently result in any loss, damage and or liability. Interest rates, fees, and charges etc., are revised from time to time, for the latest details please refer to our Pricing page.

Neither the information, nor any opinion contained in this website constitutes a solicitation or offer by BFSL or its affiliates to buy or sell any securities, futures, options or other financial instruments or provide any investment advice or service.

BFSL is acting as distributor for non-broking products/ services such as IPO, Mutual Fund, Insurance, PMS, and NPS. These are not Exchange Traded Products. For more details on risk factors, terms and conditions please read the sales brochure carefully before investing.

Investments in the securities market are subject to market risk, read all related documents carefully before investing. This content is for educational purposes only. Securities quoted are exemplary and not recommendatory.

[ Read More ]

For more disclaimer, check here : https://www.bajajbroking.in/disclaimer

Our Secure Trading Platforms

Level up your stock market experience: Download the Bajaj Broking App for effortless investing and trading

Bajaj Broking App Download

11 lakh+ Users

icon-with-text

4.6 App Rating

icon-with-text

4 Languages

icon-with-text

₹6,800+ Cr MTF Book

icon-with-text
banner-icon

Open Your Free Demat Account

Enjoy low brokerage on delivery trades

+91

|

Please Enter Mobile Number

Open Your Free Demat Account

Enjoy low brokerage on delivery trades

+91

|